JW Pharmaceutical Corporation (KRX: 001060)

Market Cap	589.10B
Revenue (ttm)	736.54B
Net Income (ttm)	69.72B
Shares Out	24.59M
EPS (ttm)	1,216.27
PE Ratio	19.36
Forward PE	6.38
Dividend	392.16 (1.67%)
Ex-Dividend Date	Dec 27, 2024

Volume	154,219
Open	24,050
Previous Close	23,650
Day's Range	24,000 - 25,100
52-Week Range	21,000 - 38,500
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 13, 2025

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 1,064
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001060

Financial Performance

In 2023, JW Pharmaceutical's revenue was 748.53 billion, an increase of 9.38% compared to the previous year's 684.35 billion. Earnings were 36.49 billion, an increase of 14.42%.